Total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data from the AdvaMed COVID-19 testing supply registry.
Manufacturers shipped nearly 8.5 million tests per week in August, up from 3.7 million weekly in April, the medtech trade group noted. AdvaMed launched the registry July 21 to aid state and federal pandemic responses.
Get the full story on our sister site, Medical Design & Outsourcing.
